13F filer · CIK 1053906
Artal Group S.A.
LUXEMBOURG, N4 · filing since Q2 2013 · last filing Aug 13, 2026
Reported value
$931.1M
$-79.5M vs prior
Positions
2
New / sold out
0 / 0
Added / reduced
1 / 1
Turnover
5.0%
buys $49.0M · sells $235.4M
Top-10 weight
100.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | Lexicon Pharmaceuticals Inc | +20,421,735 | +13.2% | +$49.0M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | Cava Group Inc | -3,000,000 | -31.6% | $-235.4M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Cava Group IncCOM | 6,507,990 | $510.7M | 54.85% |
| 2 | Lexicon Pharmaceuticals IncCOM NEW | 175,156,062 | $420.4M | 45.15% |